제품 세부정보
Synonyms
CD8A, CD8, Leu2, MAL, p32
Source
Alexa Fluor 647-Labeled Human CD8 alpha Protein, His Tag (CDA-HA2H5) is produced via conjugation of AF647 to Human CD8 alpha Protein, His Tag with a new generation site-specific technology under Star Staining labeling platform. Human CD8 alpha Protein, His Tag is expressed from human 293 cells (HEK293). It contains AA Ser 22 - Asp 182 (Accession # P01732-1).
Predicted N-terminus: Ser 22
Molecular Characterization
This protein carries a polyhistidine tag at the C-terminus.
Conjugate
AF647
Excitation Wavelength: 640 nm
Emission Wavelength: 672 nm
Protein Ratio
The AF647 to protein molar ratio is 0.8-1.
Purity
>90% as determined by SDS-PAGE.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please protect from light and avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
고객님도 확인한 상품
데이터 표시
Bioactivity-FACS

1e5 of Mouse Anti-CD8 antibody coupled beads (5.5 μm) were stained with different concentration of Alexa Fluor 647-Labeled Human CD8 alpha Protein, His Tag (Cat. No. CDA-HA2H5) and negative control protein respectively, AF647 signal was used to evaluate the binding activity (QC tested).
Protocol
1e5 of Mouse Anti-CD8 antibody coupled beads (5.5 μm) were stained with different concentration of Alexa Fluor 647-Labeled Human CD8 alpha Protein, His Tag (Cat. No. CDA-HA2H5) and negative control protein respectively, AF647 signal was used to evaluate the binding activity (QC tested).
Protocol
사용자 리뷰 댓글 남기기

배경 소개
프론티어 진행
- 영어 이름:
Cluster of differentiation 8
- 카테고리:
- 상장 의약품 수:
0 상세
- 임상 의약품 수:
18 상세
- 최고 개발 단계:
Phase 3 Clinical
전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521



















